These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17650623)

  • 1. [Decrease in the glutamate release may contribute to the neuroprotective action of the novel neuroleptic drug dilept].
    Us KS; Klodt PM; Kudrin VS; Arkhipenko NV; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2007; 70(3):3-5. PubMed ID: 17650623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of dipeptide neurotensin analog dilept on extracellular concentrations of glutamate, GABA and HVA in N. accumbens of rat brain].
    Shubenina EV; Kudrin VS; Klodt PM; Narkevich VB; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2010 Dec; 73(12):9-12. PubMed ID: 21395009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The search of small molecules with antipsychotic activity on the background of neurotensin].
    Ostrovskaia RU; Gudasheva TA; Krupina NA; Seredin SB
    Bioorg Khim; 2012; 38(1):119-26. PubMed ID: 22792715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
    Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].
    Ostrovskaia RU; Retiunskaia MV; Guzevatykh LS; Gudasheva TA; Voronina TA; Seredin SB
    Eksp Klin Farmakol; 2005; 68(1):3-6. PubMed ID: 15786954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The new tripeptoid neurotensin analog dilept selectively affects dopamine turnover in nucleus accumbens and hypothalamus].
    Retiunskaia MV; Kudrin VS; Klodt PM; Us KS; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2005; 68(6):15-8. PubMed ID: 16405028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept].
    Shubenina EB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Gudasheva TA; Voronina TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2008; 71(4):7-10. PubMed ID: 18819433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept.
    Retyunskaya MV; Guzevatykh LS; Bondarenko NA; Gudasheva TA; Ostrovskaya RU; Voronina TA
    Bull Exp Biol Med; 2003 Nov; 136(5):467-70. PubMed ID: 14968162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept].
    Zherdev VP; Boĭko SS; Mesonzhnik NV; Appolonova SA; Rodchenkov GN; Ostrovskaia RU; Gudasheva TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(3):16-21. PubMed ID: 19642587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of procognitive effect of the potential antipsychotic, Dilept and its main metabolite, GZR-125 at the novel objects recognition test in rats].
    Gorelov PI; Ostrovskaia RU; Sazonova NM
    Eksp Klin Farmakol; 2013; 76(7):3-5. PubMed ID: 24006607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neurotensin dipeptide analog dilept on dopamine metabolism and synthesis in the nucleus accumbens of Wistar rats.
    Shubenina EV; Kudrin VS; Klodt PM; Narkevich VB; Kuznetsova EA; Gudasheva TA; Ostrovskaya RU
    Bull Exp Biol Med; 2012 Sep; 153(5):694-6. PubMed ID: 23113260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
    Asmakova LS; Kalinina TS; Ostrovskaya RU; Gudasheva TA; Zaitseva NI; Bondarenko NA; Voronina TA; Seredenin SB
    Pharmacol Biochem Behav; 1999 Oct; 64(2):359-62. PubMed ID: 10515313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of N-acylprolyltyrosine "tripeptoid" analogues of neurotensin as potential atypical antipsychotic agents.
    Gudasheva TA; Voronina TA; Ostrovskaya RU; Zaitseva NI; Bondarenko NA; Briling VK; Asmakova LS; Rozantsev GG; Seredenin SB
    J Med Chem; 1998 Jan; 41(3):284-90. PubMed ID: 9464359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake.
    Colleoni S; Jensen AA; Landucci E; Fumagalli E; Conti P; Pinto A; De Amici M; Pellegrini-Giampietro DE; De Micheli C; Mennini T; Gobbi M
    J Pharmacol Exp Ther; 2008 Aug; 326(2):646-56. PubMed ID: 18451317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of emodin-8-O-beta-D-glucoside in vivo and in vitro.
    Wang C; Zhang D; Ma H; Liu J
    Eur J Pharmacol; 2007 Dec; 577(1-3):58-63. PubMed ID: 17897641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebselen protects glutamate uptake inhibition caused by methyl mercury but does not by Hg2+.
    Moretto MB; Funchal C; Santos AQ; Gottfried C; Boff B; Zeni G; Pureur RP; Souza DO; Wofchuk S; Rocha JB
    Toxicology; 2005 Oct; 214(1-2):57-66. PubMed ID: 16011868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinic pharmacokinetics of a new original antipsychotic drug Dilept].
    Shevchenko RV; Litvin AA; Kolyvanov GB; Boĭko SS; Zherdev VP; Serebrova SIu; Ivashkina NIu; Neznamov GG; Siuniakov SA
    Eksp Klin Farmakol; 2013; 76(6):34-7. PubMed ID: 24003489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism?
    Yang TT; Wang SJ
    J Pharmacol Exp Ther; 2009 Oct; 331(1):244-54. PubMed ID: 19628631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability of the blood-brain barrier for dilept and its active metabolite.
    Zherdev VP; Boyko SS; Mesonzhnik NV; Bastrygin DV
    Bull Exp Biol Med; 2011 Jul; 151(3):330-2. PubMed ID: 22451879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.